TY  - GEN
AU  - Smith,D C
AU  - Esper,P
AU  - Strawderman,M
AU  - Redman,B
AU  - Pienta,K J
TI  - Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer
SN  - 0732-183X
PY  - 2000///0113
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Neoplasms
KW  - Drug Resistance, Neoplasm
KW  - Estramustine
KW  - administration & dosage
KW  - Etoposide
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Paclitaxel
KW  - Prostatic Neoplasms
KW  - Quality of Life
KW  - Soft Tissue Neoplasms
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.1999.17.6.1664
ER  -